lactic acid has been researched along with oxidopamine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fronek, K | 1 |
Petty, F; Sherman, AD | 1 |
Dahlström, A; McRae, A | 1 |
Chen, Y; Hong, X; Liu, Z; Song, L; Wu, N; Yang, X; Yuan, W | 1 |
Che, JY; Gan, J; Liu, ZG; Song, L; Wang, WW; Xie, CL; Yuan, ML; Yuan, WE; Zhang, SF | 1 |
Arun, J; Bhatnagar, P; Chaturvedi, RK; Chaudhari, BP; Chauhan, LK; Gupta, KC; Khanna, VK; Kumar, P; Pahuja, R; Patel, DK; Saxena, PN; Seth, K; Shukla, A; Shukla, R; Shukla, RK; Singh, SP | 1 |
Alves-Dos-Santos, L; Barna, BF; Britto, LR; Chiavegatto, S; Moreira, TS; Takakura, AC; Tuppy, M | 1 |
Filiz, Z; Korkmaz, OT; Kuş, G; Şener, E; Tunçel, N; Ulupinar, E; Yelkenli, İH | 1 |
8 other study(ies) available for lactic acid and oxidopamine
Article | Year |
---|---|
Trophic effect of the sympathetic nervous system on vascular smooth muscle.
Topics: Acetylglucosaminidase; Animals; Aorta; Arteriosclerosis; Citric Acid Cycle; Cocaine; Collagen; Columbidae; Glucuronidase; Hydroxydopamines; Iliac Artery; Lactates; Lactic Acid; Muscle, Smooth, Vascular; Norepinephrine; Oxidopamine; Procollagen-Proline Dioxygenase; Rabbits; Sympathectomy, Chemical; Sympathetic Nervous System | 1983 |
A pharmacologically pertinent animal model of mania.
Topics: Affective Disorders, Psychotic; Animals; Bipolar Disorder; Disease Models, Animal; Electroshock; Humans; Hydroxydopamines; Imipramine; Injections, Intraventricular; Lactates; Lactic Acid; Lithium; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains | 1981 |
Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA induced parkinsonism.
Topics: Animals; Apomorphine; Capsules; Dopamine; Immunohistochemistry; Lactic Acid; Male; Microspheres; Neostriatum; Nerve Endings; Nerve Fibers; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Parkinson Disease, Secondary; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Stereotyped Behavior | 1994 |
Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats.
Topics: Animals; Antiparkinson Agents; Benserazide; Blotting, Western; Delayed-Action Preparations; Disease Models, Animal; Down-Regulation; Drug Carriers; Drug Combinations; Dyskinesia, Drug-Induced; Female; Lactic Acid; Levodopa; Microspheres; Oxidopamine; Parkinsonian Disorders; Phosphorylation; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, AMPA | 2012 |
Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
Topics: Adrenergic Agents; Animals; Benserazide; Blotting, Western; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Dopamine Agents; Drug Combinations; Dyskinesias; Female; Fluorescent Antibody Technique; Lactic Acid; Levodopa; Microspheres; Neurons; Oxidopamine; Parkinson Disease; Phosphoproteins; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; tau Proteins; Transcription Factors | 2014 |
Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.
Topics: Animals; Blood-Brain Barrier; Cell Line, Tumor; Dopamine; Dopaminergic Neurons; Drug Carriers; Drug Liberation; Humans; Lactic Acid; Nanoparticles; Neostriatum; Oxidation-Reduction; Oxidopamine; Parkinson Disease; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Receptors, Dopamine; Safety; Up-Regulation | 2015 |
Respiratory deficits in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Cell Count; Corpus Striatum; Disease Models, Animal; Hydrogen-Ion Concentration; Lactic Acid; Locomotion; Male; Neurons; Oxidopamine; Parkinson Disease; Psychomotor Performance; Pulmonary Ventilation; Rats; Rats, Wistar; Receptors, Neurokinin-1; Respiration Disorders; Respiratory Center; Substantia Nigra; Time Factors | 2015 |
Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.
Topics: Animals; Astrocytes; Corpus Striatum; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Gliosis; Glutamate Decarboxylase; Glutamic Acid; Glutathione; Lactic Acid; Nerve Tissue Proteins; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Vasoactive Intestinal Peptide | 2016 |